Suchergebnisse - "Moore, Patrick"

PubPharm (481)

1

Trends in clinical workload in UK primary care 2005-2019

enthalten in: The British journal of general practice : the journal of the Royal College of General Practitioners | 2024

von de Dumast, L. | Moore, P. | Snell, K. | +1

2

The predictive role of symptoms in COVID-19 diagnostic models : A longitudinal insight

enthalten in: Epidemiology and infection | 2024

von Bird, O. | Galiza, E. | Baxter, D. | +35

3

Membrane-bound Merkel cell polyomavirus middle T protein constitutively activates PLCγ1 signaling through Src-family kinases

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Peng, W. | Abere, B. | Shi, H. | +4

4

METHODS TO INCREASE IMMUNOGENICITY OF RDRP

enthalten in: Europäisches Patentamt | 2023

von MOORE PATRICK | CHANG YUAN | WAN LI

5

METHODS TO INCREASE IMMUNOGENICITY OF RDRP

enthalten in: Europäisches Patentamt | 2023

von MOORE PATRICK | CHANG YUAN | WAN LI

6

Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults : a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland

enthalten in: The Lancet. Microbe | 2023

von Ramasamy, M. | Kelly, E. | Seegobin, S. | +51

7

Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK : a randomised, observer-blind, active-controlled trial

enthalten in: The Lancet. Infectious diseases | 2023

von Lee, I. | Cosgrove, C. | Moore, P. | +64

CommentIn: Lancet Infect Dis. 2023 Sep;23(9):984-985. - PMID 37348518

8

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines : a phase 3, parallel-group study

enthalten in: EClinicalMedicine | 2023

von de Bruyn, G. | Wang, J. | Purvis, A. | +136

9

Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin

enthalten in: The New England journal of medicine | 2023

von Rosenstock, J. | Bain, S. | Gowda, A. | +107

CommentIn: Ann Intern Med. 2023 Oct;176(10):JC113. - PMID 37782932

10

Unlicensed origin DNA melting by MCV and SV40 polyomavirus LT proteins is independent of ATP-dependent helicase activity

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Wan, L. | Toland, S. | Robinson-McCarthy, L. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[49]